---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-26-000006"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:19:08.876672+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Prestige Q3 revenue $283.4M, down 2.4% YoY; adjusted EPS $1.14 vs $1.22

## Summary
- GAAP diluted EPS $0.97; adjusted diluted EPS $1.14 (down from $1.22); net income $46.7M.
- Narrowed FY2026 revenue outlook to ~$1.1B from $1.1-1.115B; adjusted EPS ~$4.54.
- Repurchased ~0.8M shares in Q3 for $45.8M; YTD repurchases ~2.3M shares at $155.6M.
- Closed acquisition of eye care supplier Pillar5 Pharma in December 2025.
- Clear Eyes supply constraints continue; management expects supply improvements in coming quarters.

## SEC filing metadata
- accession: 0001295947-26-000006
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594726000006/0001295947-26-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594726000006/pbh-20260205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-26-000006
- JSON: https://secwatch.observer/filing/0001295947-26-000006.json
- Plain text: https://secwatch.observer/filing/0001295947-26-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.